Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center
C Bastianelli, M Farris, G Benagiano - Contraception, 2011 - Elsevier
BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) was first
marketed in 1990 in Finland. Since then, it has been approved in approximately 120 …
marketed in 1990 in Finland. Since then, it has been approved in approximately 120 …
Bleeding patterns with the 19.5 mg LNG-IUS, with special focus on the first year of use: implications for counselling
V Beckert, C Ahlers, AK Frenz, C Gerlinger… - … European Journal of …, 2019 - Taylor & Francis
Objective: The aim of the study was to provide an additional, detailed description of early
bleeding patterns with the 19.5 mg levonorgestrel-releasing intrauterine system (LNG-IUS) …
bleeding patterns with the 19.5 mg levonorgestrel-releasing intrauterine system (LNG-IUS) …
Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems
D Wildemeersch, D Janssens, M Vrijens, S Weyers - Contraception, 2005 - Elsevier
OBJECTIVE: The objective of the study was to evaluate ease of insertion, contraceptive
performance and safety, in parous and nulliparous women, of two new T-shaped …
performance and safety, in parous and nulliparous women, of two new T-shaped …
The influence of the levonorgestrel‐releasing intrauterine system position on bleeding patterns in reproductive age women
RDMS Alves, MM Rabelo, VR Andrade… - … of Gynecology & …, 2019 - Wiley Online Library
Objective To determine whether users of the non‐fundal levonorgestrel‐releasing
intrauterine system (LNG‐IUS) present with unfavorable bleeding patterns more frequently …
intrauterine system (LNG‐IUS) present with unfavorable bleeding patterns more frequently …
Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning
G Grandi, R De Fata, F Varliero… - Gynecological …, 2020 - Taylor & Francis
Objective Current research informations fail to adequately inform about when levonorgestrel-
releasing intrauterine system (LNG-IUS) 52 mg is used instead of other lower dose LNG …
releasing intrauterine system (LNG-IUS) 52 mg is used instead of other lower dose LNG …
Recent developments in the clinical use of the levonorgestrel‐releasing intrauterine system
K GEMZELL‐DANIELSSON, P Inki… - Acta obstetricia et …, 2011 - Wiley Online Library
This overview focuses on recent developments in the clinical use of the levonorgestrel‐
releasing intrauterine system (LNG‐IUS) on established indications. Recent studies confirm …
releasing intrauterine system (LNG‐IUS) on established indications. Recent studies confirm …
[HTML][HTML] Immediate versus delayed insertion of the levonorgestrel intrauterine device in postpartum adolescents: a randomized pilot study
R Soon, K McGuire, J Salcedo… - Hawai'i Journal of …, 2018 - ncbi.nlm.nih.gov
This pilot study assessed the feasibility of conducting a larger randomized controlled trial
comparing the proportion of adolescents using a levonorgestrel intrauterine device (LNG …
comparing the proportion of adolescents using a levonorgestrel intrauterine device (LNG …
A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an …
G Fan, S Kang, M Ren, E Weisberg, E Lukkari-Lax… - Contraception, 2017 - Elsevier
Objective The objective was to evaluate the efficacy and safety of a low-dose levonorgestrel
intrauterine system with total content 13.5 mg (average approximately 8 μg/24 h over the first …
intrauterine system with total content 13.5 mg (average approximately 8 μg/24 h over the first …
Levonorgestrel-releasing intrauterine system–the discontinuing story
AAA Ewies - Gynecological Endocrinology, 2009 - Taylor & Francis
Levonorgestrel-releasing Intrauterine System (LNG-IUS) is licensed for use as a
contraceptive, for the treatment of heavy menstrual bleeding and during estrogen …
contraceptive, for the treatment of heavy menstrual bleeding and during estrogen …
Evidence-based selection of candidates for the levonorgestrel intrauterine device (IUD)
LS Callegari, BG Darney, EM Godfrey… - The Journal of the …, 2014 - Am Board Family Med
Background: Recent evidence-based guidelines expanded the definition of appropriate
candidates for the levonorgestrel-releasing intrauterine system (LNG-IUS). We investigated …
candidates for the levonorgestrel-releasing intrauterine system (LNG-IUS). We investigated …